According to results of a Gallup Organization survey released during the American College of Obstetricians and Gynecologists (ACOG) 57th Annual Clinical meeting in Chicago, women are delaying important preventive carein the form of pregnancy and annual check-upsas a result of the economy.
In this issue: Clopidogrel and proton pump inhibitors; adverse events with tamsulosin after cataract surgery; new guidelines for persistent pain in the elderly; and FDA Actions.
One of the most confusing areas in medicine, which spills over into obstetrics, is thrombophilia, and seemingly every year a new antibody affecting the clotting system emerges that causes worry. One of the worries involves a possible link with pre-eclampsia.
Arzoxifene is being developed by Eli Lilly and Co. to prevent bone loss and treat osteoporosis.
A review of any publication from 1960 to 2007 with the main outcome of time to fertility following oral contraceptive discontinuation was performed.
During the last two months an unusual number of papers were published which, while not having earth-shaking scientific value, should have some clinical impact.
Data from the Surveillance Epidemiology and End Results (SEER) registry have consistently demonstrated improved life expectancy for women with epithelial ovarian cancer every year since 1973.
n this issue: NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions.
